Annual Working Capital
$964.80 K
-$2.07 M-68.18%
December 1, 2023
Summary
- As of February 12, 2025, RNAZ annual working capital is $964.80 thousand, with the most recent change of -$2.07 million (-68.18%) on December 1, 2023.
- During the last 3 years, RNAZ annual working capital has risen by +$538.50 thousand (+126.32%).
- RNAZ annual working capital is now -95.22% below its all-time high of $20.20 million, reached on December 31, 2021.
Performance
RNAZ Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$1.33 M
+$444.60 K+50.29%
September 1, 2024
Summary
- As of February 12, 2025, RNAZ quarterly working capital is $1.33 million, with the most recent change of +$444.60 thousand (+50.29%) on September 1, 2024.
- Over the past year, RNAZ quarterly working capital has dropped by -$2.45 million (-64.80%).
- RNAZ quarterly working capital is now -94.22% below its all-time high of $23.00 million, reached on September 30, 2021.
Performance
RNAZ Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
RNAZ Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -68.2% | -64.8% |
| 3 y3 years | +126.3% | -94.2% |
| 5 y5 years | +581.4% | - |
RNAZ Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -95.2% | at low | -93.4% | +220.5% |
| 5 y | 5-year | -95.2% | +581.4% | -94.2% | +220.5% |
| alltime | all time | -95.2% | +581.4% | -94.2% | +220.5% |
TransCode Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.33 M(+50.3%) |
| Jun 2024 | - | $884.10 K(-77.9%) |
| Mar 2024 | - | $4.01 M(+315.4%) |
| Dec 2023 | $964.80 K(-68.2%) | $964.80 K(-74.4%) |
| Sep 2023 | - | $3.78 M(+175.7%) |
| Jun 2023 | - | $1.37 M(-224.2%) |
| Mar 2023 | - | -$1.10 M(-136.4%) |
| Dec 2022 | $3.03 M | $3.03 M(-61.1%) |
| Sep 2022 | - | $7.80 M(-36.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $12.19 M(-27.4%) |
| Mar 2022 | - | $16.79 M(-16.9%) |
| Dec 2021 | $20.20 M(+4638.0%) | $20.20 M(-12.2%) |
| Sep 2021 | - | $23.00 M(-2416.4%) |
| Jun 2021 | - | -$992.90 K(+370.6%) |
| Mar 2021 | - | -$211.00 K(-149.5%) |
| Dec 2020 | $426.30 K(+201.1%) | - |
| Dec 2020 | - | $426.30 K |
| Dec 2019 | $141.60 K | - |
FAQ
- What is TransCode Therapeutics annual working capital?
- What is the all time high annual working capital for TransCode Therapeutics?
- What is TransCode Therapeutics annual working capital year-on-year change?
- What is TransCode Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly working capital year-on-year change?
What is TransCode Therapeutics annual working capital?
The current annual working capital of RNAZ is $964.80 K
What is the all time high annual working capital for TransCode Therapeutics?
TransCode Therapeutics all-time high annual working capital is $20.20 M
What is TransCode Therapeutics annual working capital year-on-year change?
Over the past year, RNAZ annual working capital has changed by -$2.07 M (-68.18%)
What is TransCode Therapeutics quarterly working capital?
The current quarterly working capital of RNAZ is $1.33 M
What is the all time high quarterly working capital for TransCode Therapeutics?
TransCode Therapeutics all-time high quarterly working capital is $23.00 M
What is TransCode Therapeutics quarterly working capital year-on-year change?
Over the past year, RNAZ quarterly working capital has changed by -$2.45 M (-64.80%)